Medical Student Creates Pilot for Making MAT Waiver Training Part of UMASS Medical School Curriculum
Lily Rabinow, MS, a medical doctorate candidate at the University of Massachusetts Medical School (UMMS), recognized the need for physicians, in particular pediatricians, to be better trained in treating opioid use disorders with the use of medications.
Alaska Community Reaches Out to PCSS
One small, rural Alaskan community known for its famous fishing along the glacial-fed Kenai River, like so many other regions of the country has been struggling with a growing heroin crisis that has left clinicians scrambling for solutions. Central Peninsula General Hospital is a 40-bed facility located south of Anchorage that has seen a marked […]
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
We investigated prescribing patterns for five opioid use disorder (OUD) medications: 1) injectable naltrexone, 2) oral naltrexone, 3) sublingual or oromucosal buprenorphine/naloxone, 4) sublingual buprenorphine, and 5) transdermal buprenorphine in a nationally representative claims-based database (Truven Health MarketScan®) of commercially insured individuals in the United States. We calculated the prevalence of OUD in the database […]
An Evidence-Based Recommendation to Increase the Dosing Frequency of Buprenorphine During Pregnancy
Dose-adjusted plasma concentrations of buprenorphine are significantly decreased during pregnancy compared to the non-pregnant state. This observation suggests that pregnant women may need a higher dose of buprenorphine than non-pregnant individuals in order to maintain similar drug exposure (plasma concentrations over time after a dose). The current dosing recommendations for buprenorphine during pregnancy address the […]
